Simply Wall St.
Promising Penny Stocks To Consider In February 2026
📈
AI Sentiment
Highly Positive
8/10
- Home
- PETS
PETS
PetMed Express Inc.
as of 02-23-2026 3:31pm EST
$2.87
$0.08
-2.71%
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | DELRAY BEACH |
| Market Cap: | 61.6M | IPO Year: | 2003 |
| Target Price: | $3.20 | AVG Volume (30 days): | 153.2K |
| Analyst Decision: | Sell | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | quarterly |
| EPS: | -2.55 | EPS Growth: | 18.92 |
| 52 Week Low/High: | $1.57 - $4.53 | Next Earning Date: | 01-01-0001 |
| Revenue: | $273,800,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | -10.54% | Revenue Growth (next year): | 2.98% |
| P/E Ratio: | -1.13 | Index: | N/A |
| Free Cash Flow: | -395000.0 | FCF Growth: | N/A |
AI-Powered PETS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 76.43%
76.43%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest PetMed Express Inc. News
PETS Breaking Stock News: Dive into PETS Ticker-Specific Updates for Smart Investing
Compare PETS vs Leading Stocks
See how PETS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PETS PetMed Express Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.